Arvinas Inc (ARVN)
32.48
+0.71
(+2.23%)
USD |
NASDAQ |
May 01, 16:00
32.48
0.00 (0.00%)
After-Hours: 20:00
Arvinas Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -185.0% |
| June 30, 2023 | -122.2% |
| March 31, 2023 | -252.0% |
| December 31, 2022 | -219.3% |
| September 30, 2022 | -199.4% |
| June 30, 2022 | -207.1% |
| March 31, 2022 | -239.2% |
| December 31, 2021 | -159.6% |
| September 30, 2021 | -503.2% |
| June 30, 2021 | -914.5% |
| March 31, 2021 | -745.5% |
| December 31, 2020 | -657.3% |
| September 30, 2020 | -405.7% |
| Date | Value |
|---|---|
| June 30, 2020 | -438.9% |
| March 31, 2020 | -348.4% |
| December 31, 2019 | -428.2% |
| September 30, 2019 | -58.82% |
| June 30, 2019 | -427.4% |
| March 31, 2019 | -358.6% |
| December 31, 2018 | -467.6% |
| September 30, 2018 | -396.6% |
| June 30, 2018 | -231.0% |
| March 31, 2018 | -101.0% |
| December 31, 2017 | -183.8% |
| September 30, 2017 | -383.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-914.5%
Minimum
Jun 2021
-58.82%
Maximum
Sep 2019
-361.8%
Average
-300.2%
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | -23.64% |
| Bristol-Myers Squibb Co | -100.4% |
| Janux Therapeutics Inc | -477.8% |
| Geron Corp | -226.0K% |
| Verastem Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.13% |
| Return on Assets | -31.17% |
| Return on Invested Capital | -69.00% |
| Return on Net Operating Assets | -1.45K% |